TABLE 2.
Relative sensitivity for ≥CIN2 and ≥CIN3 and specificity for ≤CIN1 of Onclarity assay on self-collected compared to clinician-taken samples
Sample type | Relative sensitivity (95% CI) ≥CIN2 |
Relative sensitivity (95% CI )≥CIN3 |
Relative specificity (95% CI )≤CIN1 |
---|---|---|---|
1st vaginal | 1.01 (0.97–1.06) | 1.00 (0.94–1.06) | 0.83 (0.73–0.94) |
2nd vaginal (BD Viper LT) | 1.01 (0.97–1.06) | 1.00 (0.94–1.06) | 0.76 (0.67–0.87) |
2nd vaginal (BD COR) | 1.00 (0.95–1.05) | 0.98 (0.90–1.06) | 0.82 (0.73–0.92) |